<p>Bayer’s announcement should be read as a design and sequencing story, not as a delivered-capacity story. Bayer says it plans a $2.2 billion flexible, modular pharmaceutical manufacturing campus in New Albany, Ohio, combining drug-substance and drug-product manufacturing with advanced digital and automation technologies. The stated sequence is also clear: the first drug-substance module is expected to become operational in 2031, while a second drug-product module is planned for 2034. That gap creates an analytical lens more useful than a headline investment figure.</p> <p>Modularity can make the stages of a large programme more visible. Each module brings its own interfaces: physical utilities, automation and digital integration, workforce preparation, qualification work, and the operating decisions that have to be made before the next stage becomes useful. The question for teams building, buying or operating complex facilities is not whether a modular label is inherently better. It is whether the dependencies between modules are being surfaced early enough to test them. A later stage can still be constrained by design choices, data hand-offs or readiness requirements made earlier in the sequence.</p> <p>The release states expectations, not outcomes. Bayer expects around 600 high-value jobs at the site and roughly 1,500 construction jobs during construction; those are planned figures rather than completed employment. Similarly, the 2031 and 2034 dates should be treated as the company’s announced milestones, not as evidence that a given production, supply or performance result has occurred. Keeping those distinctions visible is an editorial choice and an operational one: it lets readers examine the architecture of the plan without assigning it results that have not been reported.</p> <p>For a related framework, insert the single approved <a href="https://supplybridge.com/procurement-transformation" target="_blank" rel="noopener noreferrer">procurement transformation buyer guide</a> link here before publication. Draft editorial question: the supplied notes do not provide the approved evergreen guide URL.</p>